These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2353926)

  • 21. Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha.
    Bruce CR; Dyck DJ
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E616-21. PubMed ID: 15149950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conjugated linoleic acid preserves gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma.
    Graves E; Hitt A; Pariza MW; Cook ME; McCarthy DO
    Res Nurs Health; 2005 Feb; 28(1):48-55. PubMed ID: 15625711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral mediation for cachexia in tumour-bearing rats.
    Tessitore L; Costelli P; Baccino FM
    Br J Cancer; 1993 Jan; 67(1):15-23. PubMed ID: 8427775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential reconstitution of mitochondrial respiratory chain activity and plasma redox state by cysteine and ornithine in a model of cancer cachexia.
    Ushmorov A; Hack V; Dröge W
    Cancer Res; 1999 Jul; 59(14):3527-34. PubMed ID: 10416620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Homeorrhetic modifications produced by a beta-agonist in the muscle and adipose tissues of the rat].
    Portillo MP; Martinez JA; Larralde J
    Reprod Nutr Dev; 1991; 31(5):509-19. PubMed ID: 1768309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.
    Mahony SM; Beck SA; Tisdale MJ
    Br J Cancer; 1988 Apr; 57(4):385-9. PubMed ID: 3390373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of muscle protein degradation in cancer cachexia.
    Smith KL; Tisdale MJ
    Br J Cancer; 1993 Aug; 68(2):314-8. PubMed ID: 8347486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous response of adipose tissue to cancer cachexia.
    Bertevello PS; Seelaender MC
    Braz J Med Biol Res; 2001 Sep; 34(9):1161-7. PubMed ID: 11514840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatty acid oxidation in lymphocytes from Walker 256 tumor-bearing rats.
    Seelaender MC; Costa-Rosa LF; Curi R
    Braz J Med Biol Res; 1996 Apr; 29(4):445-51. PubMed ID: 8736106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of systemic ketosis to control cachexia and the growth rate of the Walker 256 carcinosarcoma in rats.
    Fearon KC; Tisdale MJ; Preston T; Plumb JA; Calman KC
    Br J Cancer; 1985 Jul; 52(1):87-92. PubMed ID: 2861842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic responses to cachectin/TNF. A brief review.
    Tracey KJ; Cerami A
    Ann N Y Acad Sci; 1990; 587():325-31. PubMed ID: 2193578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins.
    Fong Y; Moldawer LL; Marano M; Wei H; Barber A; Manogue K; Tracey KJ; Kuo G; Fischman DA; Cerami A
    Am J Physiol; 1989 Mar; 256(3 Pt 2):R659-65. PubMed ID: 2784290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The oxidation of leucine in tumour-bearing rats.
    Argilés JM; López-Soriano FJ
    Biochem J; 1990 May; 268(1):241-4. PubMed ID: 2111700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nutrition modulation of cachexia/proteolysis.
    Siddiqui R; Pandya D; Harvey K; Zaloga GP
    Nutr Clin Pract; 2006 Apr; 21(2):155-67. PubMed ID: 16556926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the lipid metabolism of Walker 256 tumour-bearing rats during the development of cancer cachexia.
    Seelaender MC; Nascimento CM; Curi R; Williams JF
    Biochem Mol Biol Int; 1996 Aug; 39(5):1037-47. PubMed ID: 8866022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cachectin activity in the serum of cachectic, tumor-bearing rats.
    Stovroff MC; Fraker DL; Norton JA
    Arch Surg; 1989 Jan; 124(1):94-9. PubMed ID: 2910253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rationale for preventing cancer cachexia: targeting excessive fatty acid oxidation.
    Qian CN
    Chin J Cancer; 2016 Jul; 35(1):67. PubMed ID: 27443316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of tumour bearing on skeletal muscle glutamine metabolism.
    Parry-Billings M; Leighton B; Dimitriadis GD; Curi R; Bond J; Bevan S; Colquhoun A; Newsholme EA
    Int J Biochem; 1991; 23(9):933-7. PubMed ID: 1773899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of cachexia in parasitic infection.
    Tracey KJ; Cerami A
    Ann N Y Acad Sci; 1989; 569():211-8. PubMed ID: 2698089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.
    Tracey KJ; Wei H; Manogue KR; Fong Y; Hesse DG; Nguyen HT; Kuo GC; Beutler B; Cotran RS; Cerami A
    J Exp Med; 1988 Mar; 167(3):1211-27. PubMed ID: 3351436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.